다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
Palantir Technologies Inc (PLTR)
Palantir Technologies Inc (PLTR) 뉴스

PLTR

Palantir Technologies (PLTR)

Palantir Technologies Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:PLTR

일자	시간	출처	헤드라인	심볼	기업
2013/07/18	17:00	GlobeNewswire Inc.	U.S. National Institutes of Health Recommend to Expand Its Scope of Research in the Development of Pluristem's PLX-RAD Cells fo	LSE:PLTR
2013/07/11	16:00	GlobeNewswire Inc.	Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial	LSE:PLTR
2013/07/08	16:00	GlobeNewswire Inc.	Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells	LSE:PLTR
2013/06/26	16:00	GlobeNewswire Inc.	Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercializa	LSE:PLTR
2013/06/20	16:00	GlobeNewswire Inc.	Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE	LSE:PLTR
2013/06/19	22:00	GlobeNewswire Inc.	Pluristem Provides Update on Clinical Status of IC Trials	LSE:PLTR
2013/06/10	16:00	GlobeNewswire Inc.	Pluristem to Deliver Two Presentations During Israel's Largest Biotech Conference: IATI-BioMed	LSE:PLTR
2013/06/04	22:00	GlobeNewswire Inc.	Pluristem to Receive Clinical-hold Notice From the U.S. FDA	LSE:PLTR
2013/05/29	17:00	GlobeNewswire Inc.	Pluristem to Present at FDA Symposium	LSE:PLTR
2013/05/22	18:30	GlobeNewswire Inc.	Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nucl	LSE:PLTR
2013/05/13	16:30	GlobeNewswire Inc.	Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia	LSE:PLTR
2013/05/07	16:00	GlobeNewswire Inc.	Pluristem Develops PLX-RAD Cells for Use in Hematology	LSE:PLTR
2013/04/30	16:00	GlobeNewswire Inc.	Pluristem to Present at Needham Healthcare and Oppenheimer Israeli Investment Conferences in May 2013	LSE:PLTR
2013/04/29	16:00	GlobeNewswire Inc.	Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension	LSE:PLTR
2013/04/18	16:00	GlobeNewswire Inc.	Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine	LSE:PLTR
2013/04/11	16:00	GlobeNewswire Inc.	United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial	LSE:PLTR
2013/04/10	15:00	GlobeNewswire Inc.	Pluristem Announces Scientific and Investment Conferences for April 2013	LSE:PLTR
2013/03/20	16:00	GlobeNewswire Inc.	Pluristem Reports on the Progress of Its Phase I/II Clinical Trial for the Treatment of Muscle Injury	LSE:PLTR
2013/02/21	16:30	GlobeNewswire Inc.	Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia	LSE:PLTR
2013/02/13	21:56	GlobeNewswire Inc.	CORRECTING AND REPLACING -- Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summ	LSE:PLTR
2013/02/13	17:00	GlobeNewswire Inc.	Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summit '13	LSE:PLTR
2013/01/30	17:00	GlobeNewswire Inc.	Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility	LSE:PLTR
2013/01/22	22:00	GlobeNewswire Inc.	Pluristem Updates Cell Manufacturing Industry on Its Proprietary 3D Cell Expansion Technology at Industry Conference	LSE:PLTR
2013/01/15	18:00	GlobeNewswire Inc.	Pluristem Receives Approval to Expand Its Phase II Clinical Trial in Intermittent Claudication to Germany	LSE:PLTR
2013/01/07	21:00	GlobeNewswire Inc.	Pluristem's CEO Letter to Shareholders	LSE:PLTR
2012/12/27	17:00	GlobeNewswire Inc.	Pluristem Initiates Final Validation of New Manufacturing Facility	LSE:PLTR
2012/12/12	17:00	GlobeNewswire Inc.	Pluristem to Present at Oppenheimer 23rd Annual Healthcare Conference	LSE:PLTR
2012/12/04	17:00	GlobeNewswire Inc.	Pluristem Advances Its Intramuscular Hematology Program; Assembles Clinical Advisory Board of World Renowned Opinion Leaders	LSE:PLTR
2012/11/21	20:00	GlobeNewswire Inc.	Pluristem Reports Status of Orphan Drug Application for Aplastic Anemia	LSE:PLTR
2012/11/14	21:00	GlobeNewswire Inc.	Pluristem to Initiate a Phase I/II Clinical Trial in Muscle Injury	LSE:PLTR

검색 관련기사 보기:NYSE:PLTR

US Dollar vs Sterling

Verizon Communications

BNP Paribas (QX)

US Dollar vs Euro

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관